Cargando…

Abstract 1657: Design and Evaluation of Buforin II Variants with Enhanced DNA Binding and Antimicrobial Activity

Detalles Bibliográficos
Autores principales: Kim, Gabriela, Li, Qiao, Jing, Lisha, Radhakrishnan, Mala, Elmore, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology, Inc. Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100282/
http://dx.doi.org/10.1016/j.jbc.2023.103106
_version_ 1785025242506199040
author Kim, Gabriela
Li, Qiao
Jing, Lisha
Radhakrishnan, Mala
Elmore, Donald
author_facet Kim, Gabriela
Li, Qiao
Jing, Lisha
Radhakrishnan, Mala
Elmore, Donald
author_sort Kim, Gabriela
collection PubMed
description
format Online
Article
Text
id pubmed-10100282
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The American Society for Biochemistry and Molecular Biology, Inc. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-101002822023-04-13 Abstract 1657: Design and Evaluation of Buforin II Variants with Enhanced DNA Binding and Antimicrobial Activity Kim, Gabriela Li, Qiao Jing, Lisha Radhakrishnan, Mala Elmore, Donald J Biol Chem Topic Category Bacteria and Parasites: From Microbiome to Antibiotics The American Society for Biochemistry and Molecular Biology, Inc. Published by Elsevier Inc. 2023 2023-04-13 /pmc/articles/PMC10100282/ http://dx.doi.org/10.1016/j.jbc.2023.103106 Text en Copyright © 2023 The American Society for Biochemistry and Molecular Biology, Inc. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Topic Category Bacteria and Parasites: From Microbiome to Antibiotics
Kim, Gabriela
Li, Qiao
Jing, Lisha
Radhakrishnan, Mala
Elmore, Donald
Abstract 1657: Design and Evaluation of Buforin II Variants with Enhanced DNA Binding and Antimicrobial Activity
title Abstract 1657: Design and Evaluation of Buforin II Variants with Enhanced DNA Binding and Antimicrobial Activity
title_full Abstract 1657: Design and Evaluation of Buforin II Variants with Enhanced DNA Binding and Antimicrobial Activity
title_fullStr Abstract 1657: Design and Evaluation of Buforin II Variants with Enhanced DNA Binding and Antimicrobial Activity
title_full_unstemmed Abstract 1657: Design and Evaluation of Buforin II Variants with Enhanced DNA Binding and Antimicrobial Activity
title_short Abstract 1657: Design and Evaluation of Buforin II Variants with Enhanced DNA Binding and Antimicrobial Activity
title_sort abstract 1657: design and evaluation of buforin ii variants with enhanced dna binding and antimicrobial activity
topic Topic Category Bacteria and Parasites: From Microbiome to Antibiotics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100282/
http://dx.doi.org/10.1016/j.jbc.2023.103106
work_keys_str_mv AT kimgabriela abstract1657designandevaluationofbuforiniivariantswithenhanceddnabindingandantimicrobialactivity
AT liqiao abstract1657designandevaluationofbuforiniivariantswithenhanceddnabindingandantimicrobialactivity
AT jinglisha abstract1657designandevaluationofbuforiniivariantswithenhanceddnabindingandantimicrobialactivity
AT radhakrishnanmala abstract1657designandevaluationofbuforiniivariantswithenhanceddnabindingandantimicrobialactivity
AT elmoredonald abstract1657designandevaluationofbuforiniivariantswithenhanceddnabindingandantimicrobialactivity